KEAP1 and Hepatic fibrosis: PLS-PM results indicated that Tau positively affected the Nrf2/Keap1 pathway and negatively modulated the TLR4/NF-κB pathway, thereby improving intestinal barrier function and alleviating liver fibrosis.